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Synthesis, Crystal Structure and Cytotoxicity Studies of p-
Sulfonatocalix[4]arene Lanthanide Complexes 
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Priora, Stephen J. Archibalda,b,* and Carl Redshawa*
A number of p-sulfonatocalix[4]arene complexes of the lanthanides (Tb, Gd, and Eu) have been prepared, some in the 
presence of tetraazamacrocycle 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A), and fully characterised. Crystal 
structure determinations reveal lanthanide coordination at the sulfonate group, bridging several calixarene units, giving 
coordination polymers. All complexes in this study have been determined to be relatively non-toxic  using in vitro cell assays 
with CC50 values in the range 30 – 170 µM.   
Introduction 
The calixarenes are a major class of macrocycle synthesised by 
the condensation reaction between para substituted phenols 
and formaldehyde. One disadvantage of these macrocycles is 
that unmodified, they are highly insoluble. However with 
modification it is possible to increase the solubility of these 
macrocycles. In order for these molecules to be utilised in a 
biological setting, they must be soluble in water and so in 1984 
the first reported water soluble calixarene was reported by 
Ungaro et al.1  Also in 1984 the first calixarene derivative  with 
sulfonate groups at the para positions of the phenolic rings was 
synthesised. p-Sulfonatocalix[n]arenes (n = 4-8, Fig. 1, SCnAs) 
are a class of highly water-soluble calixarene first reported by 
Shinkai et al.2  
They are easily prepared by direct sulfonation of the exo rim of 
p-tert-butylcalix[4]arene providing sulfonic acid groups which 
allow them flexible inclusion/complexation properties.3 
Previous studies have shown that SCnAs are biocompatible4,5, in 
that they are both non-toxic and water-soluble, which makes 
them eligible for biological and pharmaceutical applications.6,7 
For these reasons, we have selected SCnAs for the present 
study. 
 A considerable amount of work on SC4A lanthanide 
complexes has been carried out previously.8-14 Work by Atwood 
et al. details the characterisation of a series of new structural 
motifs combining trivalent lanthanide ions and SC4As, and 
describes structures consisting of bi-layers of SC4A molecules 
linked by lanthanide cations as well as complex supramolecular 
assemblies.15 These assemblies consist of crown ether 
molecules sat within the hydrophobic cavity created by two 
calixarene molecules.15 This type of encapsulation is not just 
restricted to crown ethers, many other cationic, anionic, and 
neutral molecules can reside within the cavities formed by SCnA 
molecules.16-22 
 Further work by Dalgarno and Atwood, describes a 
coordination polymer formed with alternating dipyridine/SC6As 
linked with lanthanide cations, which also consists of a bi-layer 
arrangement.23 It was also demonstrated that by controlling the 
pH, structures where two SC4As envelop a crown ether 
molecule can be obtained.24 It is noted that the majority of this 
previous work concentrates on crystal engineering with little or 
no biological studies being presented. The biological 
applications of calixarenes has recently been reviewed.25 
 Another macrocycle often used for biological applications is 
1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A, 
Fig. 1 The structures of SC4A showing the exo and endo rims, and DO3A.
a. Department of Chemistry, University of Hull, UK, HU6 7RX
b. Positron Emission Tomography Research Centre, University of Hull, UK, HU6 7RX
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shown Fig. 1).26 Synthesised from the reaction between 
1,4,7,10-tetraazacyclododecane (cyclen) and t-
butylbromoacetate,27 this particular macrocycle is an efficient 
chelator of di- and tri- valent cations due to its acetate arms, 
which present strong binding donor groups.28 Derivatives of 
DO3A containing a bound gadolinium(III) ion have been utilised 
as magnetic resonance imaging (MRI) contrast agents due to the 
magnetic properties of the lanthanide. For example, a 
conjugated 2-(diphenylphosphoryl)-
ethyldiphenylphosphonium cation DO3A derivative was 
reported that exhibited low cytotoxicity and high relaxivity.29 
Uptake studies revealed a remarkable affinity for tumour cells 
and in vitro, they showed a higher T1 relaxivity measurement 
was observed compared to the clinical contrast agents 
Magnevist and Dotarem.29 The low cytotoxicity shows that 
DO3A is an excellent chelate for Gd(III) MRI contrast agents. In 
2013 an aniline benzothiazole conjugate has comparable R1 
relaxivity to Dotarem and has a specificity towards the MDA-
MB-231 breast cancer cell line.30 This shows that facile 
modification of the DO3A Chelate can allow for targeting to 
specific disease states.31 
It has been shown that attaching tetraazamacrocycle 
chelators to calixarene molecules leads to efficient contrast 
agents.32 For example   Peters et al. have conducted research 
into the use of 1,4,7,10-tetra(carboxymethyl)-1,4,7,10-
tetraazacyclododecane (DOTA) calixarene conjugates, that 
exhibit good relaxivitys, as potential MRI contrast agents.33 
These molecules form aggregates which can also accommodate 
radionuclides to produce next generation multimodal imaging 
agents combining nuclear medicine diagnostics (PET/SPECT) 
with MRI.33,34  
Both calixarenes and tetraazamacrocycles are used as metal 
chelators in the search for new biologically active metal 
complexes to combat disease. To the best of our knowledge, the 
cytotoxicity of the type of complex presented herein has not 
previously been reported. In particular, we present the 
synthesis and characterisation of SC4A lanthanide complexes 
and demonstrate their low cytotoxicity.  
Results and Discussion 
Synthesis and characterisation 
p-Sulfonatocalix[4]arene and DO3A were prepared 
according to previously described methods.38,27 
 Complexes (1), (4), and (5) were prepared by heating an 
aqueous solution of Ln(O2C2H3)3 and p-sulfonatocalix[4]arene 
for several hours and then allowing the solution to cool and 
evaporate slowly over the course of several days. 
 Complexes (3), (6), and (7) were prepared in a similar 
fashion with the addition of 1 eq. of DO3A into the aqueous 
reaction mixture.  
 Complexes (8), (9), and (10) were prepared in the same 
manner as (3), (6), and (7), however the quantity of the 
lanthanide salt used was increased by 100% in an attempt to get 
a structure with a lanthanide ion coordinated to a DO3A 
chelator. 
Complex (2) was prepared by heating an aqueous solution 
of Gd-DO3A and p-sulfonatocalix[4]arene for several hours and 
then allowing the solution to cool and evaporate slowly over the 
course of several days. Table 1. shows the molar ratios of each 
component used to synthesise each complex. 
Table 1 A summary of the molar equivalents of each component used to 
synthesise each component.
All complexes show lanthanide ions binding at the sulfonate 
groups of the SC4As and in most cases bridge two SC4As 
forming long coordination polymers. However the mass 
spectrometry results suggest that these chains of lanthanide 
bridged SC4As readily break apart in aqueous solution as much 
lower than expected molecular ion peaks are observed. 
 The structure of the ligand (Fig. 2) is comparable to a 
structure previously reported by Atwood et al. in 1988 (Fig. 3).35 
Atwood’s structure shows an SC4A molecule with a methyl 
sulfate anion residing in the cavity of the SC4A, whereas our 
structure reveals a dichloromethane molecule residing in the 
cavity.  
 For complex (1) the SC4A molecules form two discrete 
structural motifs. Both these motifs are based on Tb ions 
bridging SC4A molecules in a way seen previously by Raston et 
al. (Fig. 3).24 Both structures show SC4A molecules bridged by 
Ln ions where the coordination of the Ln ion is completed by 
water. Both structures also reveal a large number of unbound 
water molecules in their respective asymmetric units. 
 Atwood et al. published a structure very similar to complex 
(2) in 2001 (Fig. 3).36 The hetero-bimetallic cage described by 
Atwood comprised of two SC4A molecules forming a dimer 
through Na bridges with each SC4A also coordinating to one Y 
ion. The coordination about each metallic centre is completed 
by water in both structures. Complex (2) is very similar in that 
two SC4A molecules form a dimer through Na bridges with each 
SC4A also coordinating to one Gd ion, rather than one Y ion. 
 Whilst we have not been able to obtain a crystallographic 
model in which all the intricate details are resolved for complex 
(3), we have been able to extract chemically useful information 
from the data. One portion of the structure shows a DO3A 
molecule residing in the cavity of an SC4A molecule. This is not 
unlike the structure reported by Raston et al. in 200637 (Fig. 3), 
where a diprotonated diaza-12-crown-4 sits in the cavity of an 
SC4A molecule. 
Complex Ln salt (eq.) SC4A (eq.) DO3A (eq.) 
(1) 2.2 (Tb) 1 0 
(2) 1 (Gd) 1 0 
(3) 1 (Eu) 1 1 
(4) 2.2 (Gd) 1 0 
(5) 2.2 (Eu) 1 0 
(6) 1 (Tb) 1 1 
(7) 1 (Gd) 1 1 
(8) 2 (Eu) 1 1 
(9) 2 (Gd) 1 1 
(10) 2 (Tb) 1 1 
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 Comparison of the infrared spectrum of the SC4A ligand 
with those of the lanthanide complexes reveals a reduction in 
the intensity of the SO3H band (~1035 cm-1), whereas all other 
bands remain unaffected. This also confirms coordination of the 
lanthanide ion to the SO3H group on the exo rim of the SC4A. 
SC4A - Ligand (2) (3) 
(1) 
Fig. 2 Structures of the compounds synthesised for this study. 
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Atwood et al. 198835 Atwood et al. 200136 Raston et al. 200637 
Raston et al. 200424 
Fig. 3 Structures of similar compounds from the literature
Luminescence studies 
Complexes (1) (Tb), (3) (Eu), (5) (Eu), (6) (Tb), (8) (Eu), and (10) 
(Tb), were analysed in order to determine whether the 
complexes are suitable for use in optical imaging techniques. Gd 
complexes are more suited to magnetic imaging techniques and 
therefore luminescent studies have been omitted. Excitation 
wavelengths in the range λex = 320-324 nm were determined 
(Fig. S6–S8, ESI) for each complex corresponding to the SC4A.
 The emission spectra for (1), (6), and (10) showed a mixed 
spectrum with typical Tb(III) emission maximum at λem =  544 
nm overlapping the natural emission from the calixarenes (Fig. 
S5, ESI), λex = 410 nm, as shown in Fig. 4, suggesting partial 
energy transfer from the triplet state of that of the 5D6 of Tb(III). 
A similar phenomenon was seen by Stasiuk et al. with dual-
modal based probes.39 Interestingly for (3), (5), and (8) there is 
no Eu(III) emission observed suggesting the triplet state of the 
SC4A is too high in energy to efficiently excite the 5D0 of Eu(III). 
 By adding a short time delay of 0.05 ms, the fluorescence of 
the ligand is removed, as the fluorescent lifetime of the organic 
ligand (µs) is far shorter than that of the lanthanide complex 
(ms). The time delay reveals characteristic terbium peaks in the 
spectra (Fig. 5), allowing for dual fluorescent on to different 
time scales. 
 By measuring the luminescence decay of these complexes in 
deuterium oxide and then comparing it to the decay in water it 
Fig. 4 The emission spectrum of (1) without any time delay
Fig. 5 The emission spectrum of (1) with a 0.05 ms delay.
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is possible to determine the number of water molecules in the 
inner coordination sphere of the terbium atoms (qTb). An 
example of the decay curves is shown in Fig. 6 (other decay 
curves Fig. S3-S4, ESI). The number of water molecules in the 
inner coordination sphere of the terbium atom can be 
calculated using the following equation:40 
𝑞𝑇𝑏 = 5[(𝑘𝐻2𝑂 − 𝑘𝐷2𝑂) − 0.06] 
Where 𝑘𝐻2𝑂  and 𝑘𝐷2𝑂 are determined from the decay curves. In 
the case of complex (1) 𝑘𝐻2𝑂  = 6.457 and 𝑘𝐷2𝑂  = 5.394 and 
therefor qTb is calculated as 5(.015). The value calculated is an 
average for the entire sample and suggests that each terbium 
ion may coordinate up to four calixarene molecules in a 
monodentate manner. This analysis was also completed for 
complexes (6) and (10), giving qTb as 9(.146) and 8(.132) 
respectively. These values indicate monodentate coordination 
to each calixarene molecule and compliments the crystal 
structure data. 
Crystal structure determination 
SC4A (Ligand) 
A pale brown crystal was extracted from the powdery product 
after slow evaporation of the solvent. Several small crystals 
were examined and all those examined were aggregates rather 
than single crystals. The best of the crystals was chosen for data 
collection. The crystal examined showed weak scattering and a 
long exposure time was necessary (12 minutes per 1° ω-rotation 
frame). The crystal twinning was treated using Rotax. A small 
portion of the data suspected to be partially overlapped was 
omitted from the final refinement. 
 The structure contains the sulfonated calixarene, water, and 
dichloromethane (the asymmetric unit is shown in Fig. S1, ESI). 
The calixarene bowls are assembled into dimers by hydrogen 
bonding to water. The water is located on the outside of these 
dimers and crystallographically-disordered dichloromethane is 
found within the cavity formed by the two bowls. 
Supplementary C-H···π interactions are present between the 
calixarenes. A portion of the crystal structure is shown in Fig. 7. 
[(SC4A)(Tb)(SC4A)(Tb2)(SC4A)]n[ (SC4A)(Tb)(SC4A)(Tb2)(SC4A)]2 (1) 
A colourless crystal was selected for data collection. This was 
found to be a non-merohedral twin. Data were integrated using 
two twin components and the refinement used all the recorded 
data within the SHELX HKLF5 formalism. Inclusion of the second 
component in the refinement (refined twin fraction 0.16) led to 
substantial improvement in the quality of the fit. 
 The asymmetric unit contains six symmetry-unique 
calixarenes and these are bridged by eight independent terbium 
ions (Fig. 8). This produces two structural motifs. One is an 
infinite chain one calixarene wide running along b. Pairs of 
calixarenes are linked by two terbium ions and these double 
units are linked by a single terbium ion (Tb1>Tb3 in Fig. 8). Each 
terbium ion is coordinated by two sulfonate groups and six 
water molecules. The second structural motif comprises Z-
shaped clusters formed from four independent calixarenes; two 
terbium ions bridge pairs of calixarenes and these dimers are 
linked by a single terbium ion (Tb4>Tb8 in Fig. 8). The 
coordination about each terbium ion is completed by water 
such that each terbium ion is surrounded by two independent 
sulfonates and six water molecules. The Z-shaped clusters fill 
the space between the infinite chains. There is further water not 
bound to terbium that resides between the calixarenes. 
Hydrogen bonding between water, sulfonate, and the phenol 
groups helps to knit this arrangement together. There is also 
Fig. 6 The luminescence decay curves for (1). 
Fig. 7 Centrosymmetric dimer of two calixarenes encapsulating dichloromethane. 
Atoms are drawn as 30% probability ellipsoids. The right hand calixarene is generated 
by the symmetry operator i = 1-x, 1-y, 1-z. Two different orientations of the 
disordered dichloromethane are shown. Water molecules outside the dimer have 
been omitted for clarity.
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evidence for C-H···π interactions between the calixarenes. The 
infinite chain is illustrated in Fig. 9. 
[(Gd(H2O)7(SC4A)(Na(H2O))2(SC4A)(Gd(H2O)7)] (2) 
The structure crystallises in the centrosymmetric space group 
P1¯ with a single calixarene, one gadolinium ion, one sodium ion, 
and eleven bound water molecules with further unbound water 
in the asymmetric unit (Fig. S2, ESI). The gadolinium ion is bound 
only to one sulfonate and its coordination is completed by seven 
water molecules to give a square antiprismatic geometry for the 
gadolinium ion. The water is very well determined (hydrogen 
atoms located). Pairs of calixarenes are bridged by sodium 
cations. Each sodium is bound by four water molecules and 
displays a slightly distorted octahedral geometry with the pair 
of sulfonate ligands in cis configuration at the metal. The water 
is less well determined and there is some evidence of disorder. 
The bridging sodium ions produce centrosymmetric dimers of 
calixarenes as shown in Fig. 10 (the symmetry operation to 
form the dimer from the asymmetric unit is i = 1-x,2-y,-z). These 
dimers are packed in a simple primitive sheet arranged in the 
yz plane. There are multiple hydrogen bonds between adjacent 
dimers (eg two bound waters form hydrogen bonds to sulfonate 
in the next dimer). The hydrogen bonding is confined within the 
layers. 
These 2D are stacked along a with π-π interactions. 
Specifically, the ring C15>C20 forms π-π interaction with its 
symmetry equivalent (generated by i = -x, 2-y, 1-z); the distance 
between these means planes in 3.644(3) Å. Secondly the ring, 
C22>C27 forms π-π interaction with its symmetry equivalent 
(generated by i = -x, 2-y, -z); the distance between these means 
planes is 3.308(10) Å. 
 The additional unbound water is located within the cavity 
formed by the pairs of calixarenes, but none without it. It forms 
hydrogen bonds to sulfonate and phenol groups of the 
calixarenes. 
[(SC4A)2(DO3A)2Eu(H2O)6Na(H2O)3.17H2O] (3) ‡a 
The crystal examined displayed an enormous unit cell, was weakly 
scattering, displayed atomic disorder and was twinned. Unit cell 
information: space group I2/a, unit cell parameters a = 24.4740(8) Å, 
b = 43.432(2) Å, c = 22.5110(7) Å, β = 90.171(3)°, V = 23928.3(15) Å3. 
We have not been able to obtain a crystallographic model in which 
all the intricate details are resolved. However it is possible to extract 
chemically useful data from the refinements. The asymmetric unit 
has the approximate composition 
(SC4A)2(DO3A)2Eu(H2O)6Na(H2O)3.17H2O. The europium ions are 
bound by pairs of sulfonates from adjacent calixarenes to form 
dimers. The coordination about the europium ions is completed by 
water. The DO3A ligand is included in the structure but does not bind 
to the europium ions, instead it resides within the calixarene cavity. 
Two carboxylate arms of the DO3A molecule bind the sodium ion 
(Fig. 11). In a similar fashion to the other structures, a large number 
of water molecules are present outside the calixarene and these 
form an extensive hydrogen-bonding network.  
Fig. 8 Asymmetric unit of (1). Atoms drawn as 30% probability ellipsoids. Selected 
bond lengths: Tb(1)-O(34) 2.388 Å, Tb(1)-O(8) 2.353 Å, Tb(2)-O(11) 2.334 Å, Tb(2)-O(33) 
2.396 Å, Tb(3)-O(39) 2.355 Å, Tb(3)-O(1)#1 2.378 Å, Tb(4)-O(102) 2.346 Å, Tb(4)-O(68) 
2.378 Å, Tb(5)-O(66) 2.325 Å, Tb(5)-O(93) 2.359 Å, Tb(6)-O(130) 2.371 Å, Tb(6)-O(94) 
2.393 Å, Tb(7)-O(162) 2.325 Å, Tb(7)-O(128) 2.353 Å, Tb(8)-O(126) 2.344 Å, Tb(8)-
O(151) 2.353 Å.
Fig. 10 Centrosymmetric dimer formed from two calixarenes bridged by sodium 
ions. Symmetry equivalent atoms are generated by the symmetry operator i = 1-x, 2-y, -
z. Selected bond lengths: Gd(1)-O(5) 2.376 Å, Na(1)-O(11) 2.453 Å, Na(1)-O(14)#1 2.469 
Å.
Fig. 9 Portion of the infinite chain within (1) that extends along the b-axis. 
Symmetry equivalent atoms are generated by the symmetry operator i = x, 1+y, z. 
(Hydrogen atoms and water are omitted for clarity).
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[Gd13(SC4A)7(H2O)44] (4) ‡b 
Complex (4) displays an enormous asymmetric unit with 
approximate composition Gd13(SC4A)7(H2O)44 and 
centrosymmetric triclinic unit cell with parameters a = 
15.7674(10) Å, b = 25.4062(12), c = 49.535(3) Å, α = 103.035(4)°, 
β = 94.600(5)°, γ = 107.212(4) °, V = 18234.4(19) Å3. Within the 
asymmetric unit there are 13 independent Gd ions. The huge 
unit cell and presence of many unbound water molecules make 
this very challenging. It is possible to extract chemical 
information from this data set, although refinements are poor. 
The structure contains the expected calixarenes and the 
sulfonate groups coordinate to the gadolinium ions. The mode 
of bridging is similar to the other structures and the gadolinium 
ions link together the calixarenes to form dimers and trimers 
rather than polymers. The coordination about the gadolinium 
ions is completed by water. See Fig. 12 for an illustration of a 
portion of the structure. 
Cytotoxicity studies 
In order to use the optical imaging agents for future in vivo 
applications, it is essential to have an indication of toxicity. 
Given the potential biomedical applications of SCnAs, toxicity 
studies have been reported by Paclet et al. In particular they 
studied the activation of nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase in polymorphonuclear neutrophils 
(PMNs), and observed that the compounds did not stimulate 
the neutrophils.27 Subsequent in vivo experiments were carried 
out on 35S radiolabelled SC4A, showing no toxicity at 100 mg 
kg-1, equivalent to a dose of 2-5 g for humans.28To ensure the 
lanthanide complexation in this study did not have a toxicity 
level that would negatively impact on in vitro cellular studies, 
we have performed a cell viability assay. Complexes (1) - (10) 
were tested for their anti-proliferation activity against OE33 
cells. These cells were incubated for 70 h before determining 
their mitochondrial based reduction of a tetrazolium dye (MTS) 
to a formazan product which absorbs at 490 nm. This 
experiment was carried out over a range of concentrations to 
determine the amount of compound required to reduce cell 
growth by 50% (cytotoxic concentration, CC50). All compounds 
in this study are relatively non-toxic with CC50 values in the 
range 30-170 µmol. Dose response curves for treatment of 
OE33 cells with compounds (1) - (10) are shown in Fig. 13. These 
data are encouraging toward future biomedical applications. 
However, there is a preference for coordination of the 
lanthanide in the tetraazamacrocycle cavity for in vivo studies 
due to increased stability. This will be the subject of future 
studies. 
Fig. 11 A portion of the asymmetric unit of (3) showing a DO3A molecule within the 
calixarene bowl, but not binding to europium.
Fig. 12 A portion of the asymmetric unit of (4) demonstrating the presence of 
sulfonated calixarenes that are bound to gadolinium ions.
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Fig. 13 MTS assay results (top = terbium complexes, middle = gadolinium complexes, bottom = europium complexes).
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Compound SC4A (1) (2) 
Formula C29H32Cl2O23S4 C168H96O195S24Tb8 C56H68Gd2Na2O67S8 
Formula weight 947.68 7275.24 2430.06 
Crystal system Triclinic Triclinic Triclinic 
Space group P -1 P -1 P -1 
Unit cell dimensions 
a  (Å) 11.9482(10) 16.504(4) 12.2240(3) 
b  (Å) 12.3059(8) 23.227(3) 13.6903(3) 
c  (Å) 15.2457(12) 38.406(7) 14.0756(9) 
α (Å) 68.694(5) 73.798(12) 90.710(6) 
β (Å) 77.073(6) 80.363(16) 105.688(7) 
γ (Å) 89.160(6) 85.658(15) 90.843(6) 
V  (Å3) 2030.0(3) 13932(.5) 2267.23(18) 
Z 2 2 1 
Temperature (K) 150(2) 150(2) 100(2) 
Wavelength (Å) 0.71073 0.71073 0.71073 
Calculated density (Mg 
m-3) 
1.550 1.724 1.780 
Absorption coefficient 
(mm-1) 
0.452 2.301 1.762 
Transmission factors 
(min/max) 
0.925 and 0.982 0.483 and 0.768 0.722 and 1.000 
Crystal size (mm3) 0.240 x 0.060 x 0.055 0.330 x 0.310 x 0.100 0.120 x 0.060 x 0.020 
θ (max) (°) 25.433 25.316 27.483 
Reflections measured 11167 156086 30671 
Unique reflections 11167 156086 10385 
Rint 0.068 0.0571 0.0294 
Reflections with F2 > 
2σ(F2) 
5027 69332 10004 
Number of parameters 568 3557 645 
R1 [F2 > 2σ(F2)] 0.0676 0.0838 0.0443 
wR2 (all data) 0.1760 0.2453 0.1110 
GOOF, S 0.828 0.823 1.120 
Largest difference peak 
and hole (e Å-3) 
1.248 and -1.217 8.675 and -3.446 3.662 and -1.191 
Table 2    Crystal data for the ligand, complex (1), and complex (2) 
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Conclusions 
A series of lanthanide (Tb, Gd, and Eu) based SC4A complexes 
have been synthesised, characterised and screened for their 
anti-proliferation activity. Luminescence studies shows that the 
SC4A triplet state is too high in energy to efficiently excite the 
Eu based complexes, however has the ability to excite the Tb 
based complexes. The biological screening shows low CC50 
values for all complexes tested suggesting that with further 
development complexes of this type could be used for 
biomedical applications. 
Experimental section 
General remarks 
NMR spectra were recorded on a Jeol JNM ECP400 
spectrometer and a Jeol JNM-LA400, with TMS δH = 0 ppm as 
the internal standard or residual protic solvent [D2O, δH = 4.79; 
CDCl3, δH =7.26]. Chemical shifts are given in ppm (δ) and 
coupling constants (J) are given in Hertz (Hz). Peak types in the 
spectra are denoted by the following notations: broad (br), 
singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), 
sextet (sex), and multiplet (m). 
Elemental analysis were carried out by staff at the University of 
Hull. 
Infrared spectra were recorded on a Nicolet iS5 FT-IR 
spectrometer. 
Emission and excitation spectra were recorded on a Perkin 
Elmer LS 55 fluorescence spectrometer. 
X-Ray diffraction data were collected on a STOE IPSD2 image 
plate diffractometer (Hull) or a Rigaku diffractometer 
(Swansea). 
Mass spectra were obtained from the EPSRC National Mass 
Spectrometry Service Unit, Swansea University.  
p-Sulfonatocalix[4]arene and 1,4,7,10-tetraazacyclododecane-
1,4,7-triacetic acid were prepared using previously reported 
methods.24,13
Lanthanide salts were obtained from Sigma-Aldrich Company 
Ltd. and used as received. 
Synthesis of [(SC4A)(Tb)(SC4A)(Tb2)(SC4A)]n[ 
(SC4A)(Tb)(SC4A)(Tb2)(SC4A)]2 (1) 
p-Sulfonatocalix[4]arene (0.5 g, 0.67 mmol) was dissolved in 
water (10 mL). To this solution was added terbium acetate (0.5 
g, 1.49 mmol) in water (15 mL). The resulting solution was 
heated at 95°C for 2 h and then left to stir at room temperature 
overnight. The solution was concentrated in vacuo to give a buff 
powder (78 mg, 10.7%). Found: C, 30.08; H: 3.47; S: 11.98. 
Calcd. for C196H218Tb8O144.40(H2O): C, 30.31; H, 3.87; S, 11.56%. 
νmax/cm-1 3222 (w, br) H2O, 1152 (s) SO3-, 1121 (s), 1038 (s) 
SO3H. m/z 1035.3399 (SC4A-Tb(OH)8-SC4A-Tb(OH)8). 1H NMR 
(400 MHz, D2O) δ = 5.60 (br s, 8 H, Ar-H), 2.86 (br s, 8 H, Ar-
CH2-Ar). 
Synthesis of [(Gd(H2O)7)(SC4A)(Na(H2O))2(SC4A)(Gd(H2O)7)] (2) 
Gd-DO3A (0.20 g, 0.4 mmol) was dissolved in water (5 mL). To 
this solution was added p-sulfonatocalix[4]arene (0.30 g, 0.4 
mmol). The resulting mixture was heated to 95°C for 4 h. After 
cooling, the solution was neutralised with aqueous 5% sodium 
hydroxide solution following which a precipitate forms, which 
was removed by filtration. The solution was concentrated in 
vacuo to give an off-white powder (44 mg, 10.7%). Found: C, 
31.31; H, 3.54; S, 11.28. Calcd. for 
3[C56H72Gd2NaO46S8][C14H22GdN4O16].16(H2O): C, 31.36; H, 3.30; 
S, 11.04%. νmax/cm-1 3225 (w, br) H2O, 1150 (s) SO3-, 1122 (s), 
1041 (s) SO3H. m/z 457.4448 (SC4A-Gd(OH)). 
Synthesis of [(SC4A)2(DO3A)2Eu(H2O)6Na(H2O)3.17(H2O)] (3) 
DO3A (0.23 g, 0.67 mmol) was dissolved in water (10 mL) with 
stirring at 70°C. To this solution was added p—
sulfonatocalix[4]arene (0.5 g, 0.67 mmol) followed by europium 
acetate (0.22 g, 0.67 mmol). The solution was then stirred at 
90°C for 4 h. After cooling, the solution was neutralised with 
aqueous 5% sodium hydroxide solution and solid by-products 
were removed by filtration. The solution was concentrated in 
vacuo to give a cream powder (71 mg, 8.1%). Found: C, 35.02; 
H, 4.81; N, 3.92; S, 8.78. Calcd. for C42H47EuNaO22S4.10(H2O): C, 
34.95; H, 4.68; N, 3.88; S, 8.89%. νmax/cm-1 3215 (w, br) H2O, 
1151 (s) SO3-, 1122 (s), 1041 (s) SO3H. m/z 619.0297 (SC4A-Eu-
DO3A). 1H NMR (400 MHz, D2O) δ = 7.46 (s, 8 H, Ar-H), 3.91 (s, 
8 H, Ar-CH2-Ar), 3.73, 2.94 (t, 8 H, N-CH2-CH2-N), 2.38 (s, 6 
H, N- CH2-COOH), 2.28 (m, 2 H, N-CH2-CH2-N), 2.04 (m, 2 H, 
N-CH2-CH2-N), 1.90 (m, 2 H, N-CH2-CH2-N), 1.59 (m, 2 H, N-
CH2-CH2-N). 
Synthesis of [Gd13(SC4A)7(H2O)44] (4) 
p-Sulfonatocalix[4]arene (1.0 g, 1.34 mmol) was dissolved in 
water (20 mL). To this solution was added gadolinium acetate 
(1.0 g, 2.99 mmol). The resulting solution was heated at 95°C 
for 4 h. After 30 min a precipitate had formed, which was 
removed upon completion of the heating period. The filtrate 
was concentrated in vacuo to give a cream powder (100 mg, 
7.7%). Found: C, 29.55; H. 3.55; S, 11.98. Calcd. for 
C224H194Gd4O132S33.48(H2O): C, 29.49; H, 3.20; S, 11.60%. 
νmax/cm-1 3265 (w, br) H2O, 1151 (s) SO3-, 1119 (s), 1035 (s) 
SO3H. m/z 1035.3399 (SC4A-(Gd(OH)8)2-SC4A). 
Synthesis of [(Eu(H2O)9)(SC4A)(Eu(H2O)8)(SC4A)(Eu(H2O)9)] (5) 
p-Sulfonatocalix[4]arene (0.5 g, 0.67 mmol) was dissolved in 
water (10 mL). To this solution was added europium acetate 
(0.5 g, 1.52 mmol) in water (15 mL). The resulting solution was 
heated at 95°C for 2 h and then left to stir at room temperature 
overnight. The solution was concentrated in vacuo to give a 
cream powder (107 mg, 19.8%). Found: C, 28.29; H, 3.97; S, 
10.59. Calcd. for C57H97O57S8Eu3.50(H2O): C, 28.45; H, 4.06; S, 
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10.66%, νmax/cm-1 3248 (w, br) H2O, 1155 (s) SO3-, 1119 (s), 1040 
(s) SO3H. m/z 1035.3403 (SC4A-Eu(OH)3(H2O)5). 1H NMR (400 
MHz, D2O) δ 7.52 (s, 8 H, Ar-H), 3.78 (s, 8 H, Ar-CH2-Ar). 
Synthesis of 
[(Tb(H2O)9)(SC4A)(Tb(H2O)8)(SC4A)(Tb(H2O)9)(DO3A).22(H2O)] (6) 
DO3A (0.23 g, 0.67 mmol) was dissolved in water (10 mL) with 
stirring at 70°C. To this solution was added p—
sulfonatocalix[4]arene (0.5 g, 0.67 mmol) followed by terbium 
acetate (0.23 g, 0.67 mmol). The solution was then stirred at 
90°C for 4 h. Upon cooling a precipitate formed, which was 
removed by filtration. The filtrate was concentrated in vacuo to 
give a cream powder (110 mg, 17.7%). Found: C, 30.15; H, 4.40; 
N, 1.95; S, 9.37. Calcd. for C70H122N4O64S8Tb3.22(H2O): C, 30.28; 
H, 4.43; N, 2.02; S, 9.24%, νmax/cm-1 3211 (w, br) H2O, 1151 (s) 
SO3-, 1116 (s), 1038 (s) SO3H. m/z 414.3518 (Tb(OH)6-SC4A-
Tb(OH)5). 
Synthesis of 
[(Gd(H2O)9)(SC4A)(Gd(H2O)8)(SC4A)(Gd(H2O)9)(DO3A).19 (H2O)] (7) 
DO3A (0.23 g, 0.67 mmol) was dissolved in water (10 mL) with 
stirring at 70°C. To this solution was added p—
sulfonatocalix[4]arene (0.5 g, 0.67 mmol) followed by 
gadolinium acetate (0.23 g, 0.67 mmol). The solution was then 
stirred at 90°C for 4 h. Upon cooling a precipitate formed, which 
was removed by filtration. The filtrate was concentrated in 
vacuo to give a cream powder (43 mg, 6.9%). Found: C, 30.19; 
H, 4.52; N, 2.06; S, 9.40. Calcd. for C70H122N4O64S8Gd3.19(H2O): 
C, 30.33; H, 4.44; N, 2.02; S, 9.25%, νmax/cm-1 3217 (w, br) H2O, 
1148 (s) SO3-, 1116 (s), 1037 (s) SO3H. m/z 1035.3402 (SC4A-
Gd(OH)8). 
Synthesis of [(SC4A)(Eu(H2O)8)(SC4A)(Eu2(H2O)16)(SC4A).35(H2O)]n 
(8) 
DO3A (0.23 g, 0.67 mmol) was dissolved in water (10 mL) with 
stirring at 70°C. To this solution was added p—
sulfonatocalix[4]arene (0.5 g, 0.67 mmol) followed by europium 
acetate (0.44 g, 1.34 mmol). The solution was then stirred at 
90°C for 4 h. Upon cooling a precipitate formed, which was 
removed by filtration. The filtrate was concentrated in vacuo to 
give a cream powder (182 mg, 26.1%). Found: C, 32.25; H, 3.74; 
S, 12.20. Calcd. for C84H114O72S12Eu3.35(H2O): C, 32.37; H, 3.69; 
S, 12.35%, νmax/cm-1 3232 (w, br) H2O, 1150 (s) SO3-, 1117 (s), 
1038 (s) SO3H. m/z 1035.3408 (SC4A-Eu(OH)3(H2O)5). 1H NMR 
(400 MHz, D2O) δ 7.39 (s, 8 H, Ar-H), 3.97 (s, 8 H, Ar-CH2-Ar) 
Synthesis of [(SC4A)(Gd(H2O)8)(SC4A)(Gd2(H2O)16)(SC4A).44(H2O)]n 
(9) 
DO3A (0.23 g, 0.67 mmol) was dissolved in water (10 mL) with 
stirring at 70°C. To this solution was added p—
sulfonatocalix[4]arene (0.5 g, 0.67 mmol) followed by 
gadolinium acetate (0.46 g, 1.34 mmol). The solution was then 
stirred at 90°C for 4 h. Upon cooling a precipitate formed, which 
was removed by filtration. The filtrate was concentrated in 
vacuo to give a cream powder (274 mg, 39.2%). Found: C, 30.01; 
H, 5.23; S, 10.03. Calcd. for C84H114O72S12Gd3.44(H2O): C, 25.94; 
H, 5.13; S, 9.89% νmax/cm-1 3201 (w, br) H2O, 1149 (s) SO3-, 1116 
(s), 1037 (s) SO3H. m/z 1035.3416 (SC4A-Gd(OH)8). 
Synthesis of [(SC4A)(Tb(H2O)8)(SC4A)(Tb2(H2O)16)(SC4A).31(H2O)]n 
(10) 
DO3A (0.23 g, 0.67 mmol) was dissolved in water (10 mL) with 
stirring at 70°C. To this solution was added p—
sulfonatocalix[4]arene (0.5 g, 0.67 mmol) followed by terbium 
acetate (0.44 g, 1.34 mmol). The solution was then stirred at 
90°C for 4 h. Upon cooling a precipitate formed, which was 
removed by filtration. The filtrate was concentrated in vacuo to 
give a cream powder (95 mg, 13.6%). Found: C, 31.99; H, 3.54; 
S, 12.31. Calcd. for C84H114O72S12Tb3.31(H2O): C, 32.16; H, 3.66; 
S, 12.26% νmax/cm-1 3201 (w, br) H2O, 1149 (s) SO3-, 1117 (s), 
1038 (s) SO3H. m/z 1035.3404 (SC4A-Tb(H2O)8-SC4A-Tb(H2O)9). 
Crystal structure determinations 
Crystals suitable for X-ray diffraction were grown by complete 
dissolution of the complexes (1) – (4) in water and allowing the 
water to slowly evaporate. For the ligand (SC4A), the solid was 
briefly heated in dichloromethane and filtered whilst hot. The 
solvent was then allowed to slowly evaporate leaving pale 
brown crystals amongst a pale brown powder. 
 For SC4A, (1), (3), and (4), single crystal X-ray diffraction data 
were collected in a series of ω scans using a STOE IPSD2 image 
plate diffractometer utilising monochromated molybdenum 
radiation (λ = 0.71073 Å). Standard procedures were employed 
for the integration and processing of the data using X-RED.29 
Samples were coated in a thin film of perfluoropolyether oil and 
mounted at the tip of a glass fibre located on a goniometer. 
Data were collected from crystals held at 150K in an Oxford 
Instruments nitrogen gas cryostream. 
 Crystal structures were solved using routine automatic 
direct methods implemented within SHELXS-97.30 Completion 
of structures was achieved by performing least squares 
refinement against all unique F2 values using SHELX-97.30 
 For (2), data were collected by the EPSRC National 
Crystallography Service31 using a Rigaku diffractometer with a 
molybdenum rotating anode and Rigaku Saturn724+ detector. 
The crystal was kept at 100K for the data collection. 
Cytotoxicity 
MTS assay is based upon the conversion of tetrazolium salt to 
into formazan in viable cells via mitochondrial dehydrogenase 
enzyme activity. The amount of formazan is directly 
proportional to the number of viable cells in the culture media. 
OE33 (oesophageal carcinoma) cells were seeded in 96 flat 
bottomed microtiter tissue culture plates with 1000 cells/well 
in 200 μL media (RPMI + 1% glutamine + 10% FCS). The plates 
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were incubated overnight in a 5% CO2 incubator at 37°C to allow 
cells to adhere. The next day the media was removed from the 
wells and 100 μL compound in media was added. Tested 
compounds were used in a range of concentrations from 0.91 
μM to 2 mM. The plates were then returned to a 5% CO2 
incubator for 72 h after which MTS reagent (Promega, UK) 20 
μL was added to each well and returned to the incubator at 37°C 
for a further 3 h. Absorbance readings were taken at 490 nm 
using a Synergy HT microplate reader (Biotek, USA). 
Experiments were carried out in triplicate and subtracted from 
media only absorbance.  CC50 values were obtained using 
GraphPad Prism 5 (GraphPad, USA) software. 
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Notes and references 
‡ CCDC 1449711 - 1449713 contain the supplementary 
crystallographic data for this paper. These data can be obtained 
free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. 
‡a Complex (3) displayed an enormous unit cell and was twinned. It 
displayed atomic disorder and there are large regions of the 
structure contain diffuse electron density, probably due to poorly-
ordered water molecules. We do not claim this structure is finished 
and suitable for deposition in the CCDC or wish to report the 
refinement details. However, refinements against the data available 
give (we believe unequivocally) useful chemical information about 
the nature of the molecules present and their coordination to 
europium and sodium ions.  
‡b Complex (4) has similar problems: a huge unit cell including 13 
crystallographically independent gadolinium ions and large volumes 
of space occupied by poorly-ordered solvent. As for (3), we do not 
consider that we have derived a model of the complete crystal 
structure but we can identify key chemically-intelligible features that 
add to our understanding of this compound. We do not claim this 
structure is finished and suitable for deposition in the CCDC or wish 
to report the refinement details.  
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